Salvage surgery following downstaging of advanced non‐small cell lung cancer by targeted therapy

Abstract Background Advanced non‐small cell lung cancer (NSCLC) accounts for a high proportion of lung cancer cases. Targeted therapy improve the survival in these patients, but acquired drug resistance will inevitably occur. If tumor downstaging is achieved after targeted therapy, could surgical re...

Full description

Bibliographic Details
Main Authors: Kuo Li, Xiaonian Cao, Bo Ai, Han Xiao, Quanfu Huang, Zheng Zhang, Qian Chu, Li Zhang, Xiaofang Dai, Yongde Liao
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:Thoracic Cancer
Subjects:
Online Access:https://doi.org/10.1111/1759-7714.14044